David Andrews

2.8k total citations
65 papers, 1.6k citations indexed

About

David Andrews is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David Andrews has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 19 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in David Andrews's work include Chemical Synthesis and Analysis (8 papers), Glycosylation and Glycoproteins Research (7 papers) and Hepatitis C virus research (7 papers). David Andrews is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Glycosylation and Glycoproteins Research (7 papers) and Hepatitis C virus research (7 papers). David Andrews collaborates with scholars based in United Kingdom, United States and Singapore. David Andrews's co-authors include A. Benedict Cosimi, John R. Kitchin, D. Dahl, W S Lane, Robert T. McCluskey, A. Bignami, Philip C. Bulman Page, James J. Dowling, David H. Sachs and George Perides and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

David Andrews

65 papers receiving 1.6k citations

Peers

David Andrews
Harald S. Conradt Germany
Esteban S. Masuda United States
L C Andersson Finland
Karl W. Mollison United States
Robert C. Boltz United States
Mark A. Tepper United States
Xin He China
Stephan Arni Switzerland
Tracy Keller United States
Dorothy Hudig United States
Harald S. Conradt Germany
David Andrews
Citations per year, relative to David Andrews David Andrews (= 1×) peers Harald S. Conradt

Countries citing papers authored by David Andrews

Since Specialization
Citations

This map shows the geographic impact of David Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Andrews more than expected).

Fields of papers citing papers by David Andrews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Andrews. The network helps show where David Andrews may publish in the future.

Co-authorship network of co-authors of David Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of David Andrews. A scholar is included among the top collaborators of David Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Andrews. David Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Abigail J., Emily G. Baker, Andrew Herman, et al.. (2023). Design and Selection of Heterodimerizing Helical Hairpins for Synthetic Biology. ACS Synthetic Biology. 12(6). 1845–1858. 2 indexed citations
2.
Andrews, David. (2023). A Patient’s Wish List for Imaging Artificial Intelligence (and Radiology). Journal of the American College of Radiology. 20(9). 868–869. 1 indexed citations
3.
Smith, Abigail J., Emily G. Baker, Orion D. Weiner, et al.. (2022). From peptides to proteins: coiled-coil tetramers to single-chain 4-helix bundles. Chemical Science. 13(38). 11330–11340. 15 indexed citations
4.
Hóbor, Fruzsina, Thomas James, Gail J. Bartlett, et al.. (2021). Query-guided protein–protein interaction inhibitor discovery. Chemical Science. 12(13). 4753–4762. 7 indexed citations
5.
Andrews, David, Sabina Cosulich, Nullin Divecha, et al.. (2021). Identification and optimization of a novel series of selective PIP5K inhibitors. Bioorganic & Medicinal Chemistry. 54. 116557–116557. 7 indexed citations
6.
Andrews, David, Paul Edwards, David Fox, et al.. (2016). The creation and characterisation of a National Compound Collection: the Royal Society of Chemistry pilot. Chemical Science. 7(6). 3869–3878. 5 indexed citations
7.
Andrews, David, Martin E. Swarbrick, & Andrew T. Merritt. (2014). Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface. Drug Discovery Today. 19(4). 496–501. 8 indexed citations
8.
Bradbury, Robert H., Neil J. Hales, Alfred A. Rabow, et al.. (2011). Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer. Bioorganic & Medicinal Chemistry Letters. 21(18). 5442–5445. 36 indexed citations
9.
Kawai, Tatsuo, Hiroshi Sogawa, Svetlan Boskovic, et al.. (2004). CD154 Blockade for Induction of Mixed Chimerism and Prolonged Renal Allograft Survival in Nonhuman Primates. American Journal of Transplantation. 4(9). 1391–1398. 162 indexed citations
10.
Andrews, David, Martin R. Johnson, Paul S. Jones, et al.. (2003). The design of potent, non-peptidic inhibitors of hepatitis C protease. European Journal of Medicinal Chemistry. 38(4). 339–343. 12 indexed citations
11.
Andrews, David, et al.. (2003). Design and synthesis of spiro-cyclopentenyl and spiro--dithiolanyl substituted pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease. Bioorganic & Medicinal Chemistry Letters. 13(10). 1657–1660. 6 indexed citations
12.
Slater, Martin J., David Andrews, Berwyn Clarke, et al.. (2002). Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease. Bioorganic & Medicinal Chemistry Letters. 12(23). 3359–3362. 13 indexed citations
13.
Kawai, Tatsuo, A. Benedict Cosimi, S L Wee, et al.. (2002). Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys1. Transplantation. 73(11). 1757–1764. 90 indexed citations
14.
Kozłowski, Tomasz, Francesco L. Ierino, Denis Lambrigts, et al.. (1998). Depletion of anti‐Galα1–3Gal antibody in baboons by specific α‐Gal immunoaffinity columns. Xenotransplantation. 5(2). 122–131. 96 indexed citations
15.
Kozłowski, Tomasz, Yasushi Fuchimoto, Michael T. Bailin, et al.. (1997). Apheresis and column absorption for specific removal of Gal-α-1,3 Gal natural antibodies in a pig-to-baboon model. Transplantation Proceedings. 29(1-2). 961–961. 20 indexed citations
16.
Gough, Andrew, David Andrews, P. A. Bacon, & P. Emery. (1995). EVIDENCE OF OMEPRAZOLE-INDUCED SMALL BOWEL BACTERIAL OVERGROWTH IN PATIENTS WITH SCLERODERMA. Lara D. Veeken. 34(10). 976–977. 22 indexed citations
17.
Page, Philip C. Bulman, Jag Heer, Donald Bethell, E. W. COLLINGTON, & David Andrews. (1995). ChemInform Abstract: Highly Enantioselective Catalytic Asymmetric Oxidation of Sulfides Using Hydrogen Peroxide.. ChemInform. 26(47). 1 indexed citations
18.
Gharbia, Saheer E., et al.. (1995). Genomic Clusters and Codon Usage in Relation to Gene Expression in Oral Gram-negative Anaerobes. Anaerobe. 1(5). 239–262. 8 indexed citations
19.
Shah, Haroun N. & David Andrews. (1994). Malate dehydrogenase and glucose-6-phosphate dehydrogenase, key markers for studying the genetic diversity ofActinobacillus actinomycetemcomitans. FEMS Microbiology Letters. 122(1-2). 69–73. 3 indexed citations
20.
Andrews, David, et al.. (1991). Solid‐phase synthesis of a range of O‐phosphorylated peptides by post‐assembly phosphitylation and oxidation. International journal of peptide & protein research. 38(5). 469–475. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harald S. Conradt Breakdown of academic impact, for papers by Esteban S. Masuda Breakdown of academic impact, for papers by L C Andersson Breakdown of academic impact, for papers by Karl W. Mollison Breakdown of academic impact, for papers by Robert C. Boltz Breakdown of academic impact, for papers by Mark A. Tepper Breakdown of academic impact, for papers by Xin He Breakdown of academic impact, for papers by Stephan Arni Breakdown of academic impact, for papers by Tracy Keller Breakdown of academic impact, for papers by Dorothy Hudig
Rankless by CCL
2026